1,818
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Telmisartan mitigates lipopolysaccharide (LPS)-induced production of mucin 5AC (MUC5AC) through increasing suppressor of cytokine signaling 1 (SOCS1)

, , , , , , & ORCID Icon show all
Pages 3912-3923 | Received 17 Mar 2021, Accepted 11 Jun 2021, Published online: 19 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jia Liang, RuoXiao Zhuang, XueYao Sun, Feng Zhang & Bin Zou. (2021) Apremilast mitigates interleukin (IL)-13-induced inflammatory response and mucin production in human nasal epithelial cells (hNECs). Bioengineered 12:1, pages 8583-8593.
Read now

Articles from other publishers (2)

Mi Zhou, Ling Meng, Qinke He, Chunguang Ren & Changyi Li. (2024) Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways. Frontiers in Pharmacology 15.
Crossref
Yanqiu Gao, Shuangfeng Li, Rui Dong & Xiaoyan Li. (2022) Long noncoding RNA MIR3142HG accelerates lipopolysaccharide-induced acute lung injury via miR-95-5p/JAK2 axis. Human Cell 35:3, pages 856-870.
Crossref